相关实验视频
Updated: Jul 25, 2026

09:53
In vivo Imaging of Transgenic Leishmania Parasites in a Live Host
Published on: July 27, 2010
15.9K
在莱什曼病的FcRγIIA反应二元性
Ikram Hammi1, Julien Giron-Michel2, Khadija Akarid3
1Health & Environment Laboratory, Ain Chock Faculty of Sciences, Hassan II University of Casablanca (UH2C), Morocco; INSERM UMR-S-MD 1197, Ministère des Armées et Université Paris Saclay, Villejuif, France.
Microbial pathogenesis
|November 18, 2024
概括
莱什曼尼亚寄生虫通过劫持像Fc马受体IIA (FcγRIIA) 这样的免疫受体来逃避宿主免疫. 了解这种相互作用可能会揭示莱什曼病的新治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 寄生虫学的寄生虫学
- 热带疾病 热带疾病
背景情况:
- 莱什曼病导致了一个被忽视的热带疾病,影响全球数以百万计的人,可能因气候变化而扩散.
- 寄生虫采用复杂的免疫逃避策略,操纵宿主细胞并沉默关键的免疫反应.
- Fc受体通过促进抑制途径参与微生物免疫逃避.
研究的目的:
- 探索Fc玛受体IIA (FcγRIIA) 在莱什曼病中的潜在作用.
- 调查Leishmania如何利用FcγRIIA及其下游信号通路进行免疫逃避.
主要方法:
- 本综述综合了目前关于Leishmania与宿主免疫受体相互作用的知识.
- 专注于FcγRIIA和相关信号级联的特定作用.
主要成果:
- 在感染初期,Leishmania积极操纵宿主免疫反应.
- FcγRIIA被确定为寄生虫利用的潜在关键受体.
- 寄生虫与FcγRIIA的相互作用可能导致抑制重要的细胞防御.
结论:
- 了解Leishmania与FcγRIIA的相互作用,可以了解寄生虫免疫逃避机制.
- 准FcγRIIA通路是一个潜在的治疗策略,可以增强宿主对莱什曼病的免疫力.
相关概念视频
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

